Oncotherapeutics
Full Service Contract Research Organization (CRO)
About Us
Clinical Trials
Publications
Links
Become an Investigator
Contact Us
About Us
Clinical Trials
Publications
Links
Become an Investigator
Contact Us
Manuscripts Published in 2008
Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss
Clinical Cancer Research, October 2008
View Article
Subscribe to our Mailing List
Recent Posts
ASCO 2018: Results of Phase 1 study of Ruxolitinib
Incyte Phase 1 study of ruxolitinib, steroids and lenalidomide
BMS Phase 2 trial of the efficacy and safety of Elotuzumab
Bio-Cancer Treatment International Ltd. Recombinant human Arginase 1 (rhArg1)
BMS Phase 2 single arm study of safety of Elotuzumab
Contact Us
9201 W. Sunset Blvd., Ste. 317
West Hollywood, CA 90069
(310) 623-1200 tel
(310) 623-1121 fax